These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 776494)

  • 41. Sensitizers and protectors in radiotherapy.
    Brown JM
    Cancer; 1985 May; 55(9 Suppl):2222-8. PubMed ID: 2983876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiosensitizers.
    Hellmann K
    Antibiot Chemother (1971); 1978; 23():58-63. PubMed ID: 646329
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells.
    Moore BA; Palcic B; Skarsgard LD
    Radiat Res; 1976 Sep; 67(3):459-73. PubMed ID: 959489
    [No Abstract]   [Full Text] [Related]  

  • 44. The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans.
    Allen JG; Dische S; Lenox-Smith I; Malcolm SL; Saunders MI
    Eur J Clin Pharmacol; 1984; 27(4):483-9. PubMed ID: 6519157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical study on radiotherapy in combination with misonidazole].
    Ono K; Takahashi M; Dodo Y; Abe M
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
    [No Abstract]   [Full Text] [Related]  

  • 46. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
    Ono K; Sasai K; Shibamoto Y; Tsutsui K; Fushiki M; Nishidai T; Takahashi M; Abe M
    Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cisplatin as a radiosensitizer in the treatment of solid tumours--a clinical pilot study].
    Higi M; Schreiber D; Arndt D; Henning A; Schmitt G
    Strahlentherapie; 1982 Oct; 158(10):616-9. PubMed ID: 6758215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
    Brown JM
    Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322
    [No Abstract]   [Full Text] [Related]  

  • 49. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
    Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
    Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The application in radiation therapy of substances which modify cellular radiation response.
    Chapman JD; Urtasun RC
    Cancer; 1977 Jul; 40(1 Suppl):484-8. PubMed ID: 195712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of hyperthermia on cytotoxicity of the radiosensitizer Ro-07-0582 in a solid mouse tumour.
    George KC; Hirst DG; McNally NJ
    Br J Cancer; 1977 Mar; 35(3):372-5. PubMed ID: 851513
    [No Abstract]   [Full Text] [Related]  

  • 52. Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120.
    Drugs R D; 2004; 5(1):52-7. PubMed ID: 14725495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Enhancement of the effect of radiotherapy of Guerin's carcinoma by tinidazole].
    Nonko VD; Baran LA; Rudakov NP; Gol'dshmid BIa; Kurliand VA
    Eksp Onkol; 1987; 9(2):64-6. PubMed ID: 3582244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.
    Rhomberg W; Hassenstein EO; Gefeller D
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1077-84. PubMed ID: 8985029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG; Russo A; Gamson J; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
    Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
    Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582.
    Denekamp J; Morris C; Field SB
    Radiat Res; 1977 May; 70(2):425-32. PubMed ID: 860014
    [No Abstract]   [Full Text] [Related]  

  • 58. A phase I/II evaluation of metoclopramide as a radiosensitiser in patients with inoperable squamous cell carcinoma of the lung.
    Kjellén E; Pero RW; Brun E; Ewers SB; Jarlman O; Knöös T; Malmström P; Tennvall J; Killander D; Olsson A
    Eur J Cancer; 1995 Dec; 31A(13-14):2196-202. PubMed ID: 8652242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
    Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.
    Sheldon PW; Fowler JF
    Br J Cancer Suppl; 1978 Jun; 3():242-5. PubMed ID: 277239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.